Clinical Trial Update: CR9112792, a Follow-up of Study CR9108963

View source ↗

Summary

Clinical trial CR9112792, a follow-up of CR9108963, has completed its investigation in osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• CR9112792

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoporosis | Status: COMPLETED